EPISODE · Feb 4, 2026 · 30 MIN
Ophthalmology Perspectives | Ep 3 | Gene Therapy, Patient-Centric Operations, and Risk-Benefit Challenges in Phase 1 Ophthalmology Trials
from The Fortrea Podcast · host Marina
Today we explore the unique challenges and opportunities in Phase 1 ophthalmology clinical trials, focusing on gene therapy and inherited retinal diseases. Host: Amber BurgParticipants: David Hoelscher, Senior Medical Director, Ophthalmology Tanya Richardson, Therapeutic Strategy Head, Ophthalmology and Neuroscience
What this episode covers
Today we explore the unique challenges and opportunities in Phase 1 ophthalmology clinical trials, focusing on gene therapy and inherited retinal diseases. Host: Amber Burg Participants: David Hoelscher, Senior Medical Director, Ophthalmology Tanya Richardson, Therapeutic Strategy Head, Ophthalmology and Neuroscience
NOW PLAYING
Ophthalmology Perspectives | Ep 3 | Gene Therapy, Patient-Centric Operations, and Risk-Benefit Challenges in Phase 1 Ophthalmology Trials
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m